|
US 12,264,154 B2 |
|
| Compounds and methods of use |
| Kevin M. Cottrell, Arlington, MA (US); and John P. Maxwell, Hingham, MA (US) |
| Assigned to Tango Therapeutics, Inc., Boston, MA (US) |
| Filed by Tango Therapeutics, Inc., Boston, MA (US) |
| Filed on Feb. 1, 2024, as Appl. No. 18/430,456. |
| Application 18/430,456 is a continuation of application No. 17/732,846, filed on Apr. 29, 2022, granted, now 11,999,727. |
| Application 17/732,846 is a continuation of application No. 17/525,692, filed on Nov. 12, 2021, granted, now 11,492,350, issued on Nov. 8, 2022. |
| Application 17/525,692 is a continuation of application No. PCT/US2021/044004, filed on Jul. 30, 2021. |
| Claims priority of provisional application 63/059,959, filed on Jul. 31, 2020. |
| Prior Publication US 2024/0228478 A1, Jul. 11, 2024 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C07D 417/14 (2006.01); A61P 35/00 (2006.01) |
